Open-Label Extension Safety Study of PROCRIT in Patients With Anemia of Chronic Disease Due to Rheumatoid Arthritis

NCT00123149 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Anemia
Rheumatoid Arthritis

Interventions

DRUG: Epoetin alfa

Sponsor

Ortho Biotech Products, L.P.